Cencora, Inc. Files 8-K for Material Definitive Agreement
Ticker: COR · Form: 8-K · Filed: Apr 23, 2024 · CIK: 1140859
| Field | Detail |
|---|---|
| Company | Cencora, INC. (COR) |
| Form Type | 8-K |
| Filed Date | Apr 23, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $1,450,000,000, $250,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, financial-obligation, corporate-action
TL;DR
Cencora just signed a big deal, creating a new financial obligation. Details in the 8-K.
AI Summary
On April 17, 2024, Cencora, Inc. entered into a Material Definitive Agreement related to a direct financial obligation. The filing details the creation of this obligation under an off-balance sheet arrangement. Specific details regarding the nature of the agreement and the financial obligation are provided within the filing.
Why It Matters
This filing indicates a significant financial commitment or obligation for Cencora, Inc., which could impact its financial structure and future operations.
Risk Assessment
Risk Level: medium — Material definitive agreements and new financial obligations can introduce financial risks and operational changes for a company.
Key Players & Entities
- Cencora, Inc. (company) — Registrant
- April 17, 2024 (date) — Date of earliest event reported
FAQ
What type of Material Definitive Agreement did Cencora, Inc. enter into?
The filing indicates the entry into a Material Definitive Agreement that involves the creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported is dated April 17, 2024.
What is Cencora, Inc.'s former company name?
Cencora, Inc.'s former company name was AmerisourceBergen Corp.
When did the name change from AmerisourceBergen Corp to Cencora, Inc. occur?
The date of the name change was May 17, 2001.
What is Cencora, Inc.'s primary business as indicated by its SIC code?
Cencora, Inc.'s Standard Industrial Classification (SIC) code is 5122, which corresponds to Wholesale-Drugs Proprietaries & Druggists' Sundries.
Filing Stats: 948 words · 4 min read · ~3 pages · Grade level 13.8 · Accepted 2024-04-23 16:31:06
Key Financial Figures
- $1,450,000,000 — tization facility has a base limit of US$1,450,000,000, with an option to increase the commitm
- $250,000,000 — t to their approval, by an additional US$250,000,000 for seasonal needs during the December
Filing Documents
- tm2412226d1_8k.htm (8-K) — 35KB
- tm2412226d1_ex10-1.htm (EX-10.1) — 450KB
- 0001104659-24-050615.txt ( ) — 723KB
- cor-20240417.xsd (EX-101.SCH) — 3KB
- cor-20240417_lab.xml (EX-101.LAB) — 33KB
- cor-20240417_pre.xml (EX-101.PRE) — 22KB
- tm2412226d1_8k_htm.xml (XML) — 3KB
01
Item 1.01 Entry into Material Definitive Agreement Amendment of Securitization Facility On April 17, 2024, Cencora, Inc. (the " Company ") and certain of its subsidiaries entered into an Omnibus Amendment (the " Omnibus Amendment ") with MUFG Bank, Ltd., as administrator, and the purchaser agents and purchasers party thereto, constituting (i) the Twentieth Amendment to Amended and Restated Receivables Purchase Agreement (the " Twentieth RPA Amendment ") among Amerisource Receivables Financial Corporation (" ARFC "), as seller, AmerisourceBergen Drug Corporation (" ABDC "), as servicer, the purchaser agents and purchasers party thereto, and MUFG Bank, Ltd., as administrator, (ii) the Second Amendment to Amended and Restated Receivables Sale Agreement (the " Second RSA Amendment ") among ARFC, as buyer, and ABDC and ASD Specialty Healthcare, LLC (" ASD "), as originators, and (iii) the First Amendment to Second Amended and Restated Performance Undertaking (the " Performance Undertaking Amendment ") made by the Company, as performance guarantor, in favor of ARFC, as buyer. The Twentieth RPA Amendment: Extended the scheduled facility termination date from October 21, 2025 to October 21, 2026; Added U.S. Bank National Association and Truist Bank as committed purchasers, uncommitted purchasers, and purchaser agents, and removed Mizuho Bank, Ltd, as a committed purchaser, uncommitted purchaser, and purchaser agent; Added certain representations and warranties regarding compliance with laws and agreements; and Effected certain other technical changes. Each of the Second RSA Amendment and the Performance Undertaking Amendment made certain technical changes to reflect the Company's updated name, Cencora, Inc. The securitization facility is available to provide additional liquidity and funding for the ongoing business needs of the Company and its subsidiaries. Availability under the securitization facility is based on the accounts receivables originated by ABDC
03. Creation of Direct Financial
Item 2.03. Creation of Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in Item 1.01 above is hereby incorporated by reference into this Item 2.03.
01 Financial
Item 9.01 Financial (d) Exhibits. Exhibit Number Description 10.1 Omnibus Amendment, dated as of April 17, 2024, constituting (i) the Twentieth Amendment to Amended and Restated Receivables Purchase Agreement among ARFC, as seller, ABDC, as servicer, the purchaser agents and purchasers party thereto, and MUFG Bank, Ltd., as administrator, (ii) the Second Amendment to Amended and Restated Receivables Sale Agreement among ARFC, as buyer, and ABDC and ASD Specialty Healthcare, LLC, as originators, and (iii) the First Amendment to Second Amended and Restated Performance Undertaking made by the Company, as performance guarantor, in favor of ARFC, as buyer. 104 The cover page of this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cencora, Inc. April 23, 2024 By: /s/ James F. Cleary Name: James F. Cleary Title: Executive Vice President and Chief Financial Officer